# Matinas Biopharma (MTNB) — Overview

MTNB · AMEX · Stock

Canonical page: https://www.lighthorse.io/tickers/mtnb

## Price

Last close $2.42 on Oct 15, 2026. 52-week range $2.40 – $28.50.

## Company profile

Matinas BioPharma Holdings Inc is a clinical-stage biopharmaceutical company with a focus on identifying and developing novel pharmaceutical products. The firm's pipeline includes MAT2203, MAT2501, and others. Its LNC platform enables safe, intracellular, oral- delivery of small molecules and small oligonucleotides.

## Financials

| Metric | Value |
| --- | --- |
| Revenue (trailing twelve months) | $0.00 |
| Revenue (quarter) | $0.00 |
| Revenue growth (year over year) | 0.00% |
| Gross profit (trailing twelve months) | $0.00 |
| Gross margin | 0.00% |
| Net income (trailing twelve months) | $0.00 |
| Net income (quarter) | −$1.3M |
| Net income growth (year over year) | 74.72% |
| Net margin | 0.00% |
| Return on equity | -154.28% |
| EPS (trailing twelve months) | −$8.29 |
| Book value per share | $4.21 |
| P/E (trailing twelve months) | — |
| Price to book | 1.3 |
| Debt to assets | 47.25% |
| Payout ratio | 0.00% |
| Dividend yield | 0.00% |

## Frequently Asked Questions

### How do I buy stock in Matinas Biopharma (MTNB)?

MTNB trades commission-free with a Light Horse Securities brokerage account — from the mobile app, the web at [Light Horse Dashboard](https://portal.lighthorse.io), the trading API, or an [AI agent connected over MCP](/instructions/ai/claude). The trade panel on this page places the order once you are signed in.

---

Quotes and charts are not real-time and must not be relied on for trade decisions or valuation.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).